mRNA

© The Deoxyribonucleic acid Universe/istockphoto/KJN

On the Dark Equus caballus Podcast, Dr. Robert Malone, creator of mRNA vaccine technology, said the COVID vaccine lipid nanoparticles — which tell the body to produce the spike protein — leave the injection site and accrue in organs and tissues.

On June 10, Dr. Robert Malone, creator of mRNA vaccine engineering, joined evolutionary biologist Bret Weinstein, Ph.D., for a iii-hour conversation on the Dark Horse Podcast to discuss multiple rubber concerns related to the Pfizer and Moderna vaccines.

In this short outtake from the full podcast, Malone, Weinstein and tech entrepreneur Steve Kirsch bear on the implications of the controversial Japanese Pfizer biodistribution report . The report was made public earlier this month by Dr. Byram Bridle, a viral immunologist.

They also hash out the lack of proper animate being studies for the new mRNA vaccines, and the theory , consort past virologist Geert Vanden Bossche, Ph.D., that mass vaccination with the mRNA vaccines could produce always more than transmissible and potentially deadly variants.

As The Defender reported June 3, Determent received a copy of a Japanese biodistribution report — which had been kept from the public — as a outcome of a freedom of information request made to the Japanese authorities for Pfizer data.

Prior to the study'due south disclosure, the public was led to believe past regulators and vaccine developers that the spike protein produced past mRNA COVID vaccines stayed in the shoulder where it was injected and was not biologically active — fifty-fifty though regulators around the world had a copy of the report which showed otherwise.

The biodistribution written report obtained past Bridle showed lipid nanoparticles from the vaccine did not stay in the deltoid muscle where they were injected equally the vaccine's developers claimed would happen, but circulated throughout the body and accum ulated in large concentrations in organs and tissues, including the spleen, bone marrow, liver, adrenal glands and — in "quite loftier concentrations" — in the ovaries.

The mRNA — or messenger RNA — is what tells the body to industry the fasten protein. The lipid nanoparticles are like the "boxes" the mRNA is shipped in, co-ordinate to Malone. "If yous find lipid nanoparticles in an organ or tissue, that tells y'all the drug got to that location," Malone explained.

According to the data in the Japanese written report, lipid nanoparticles were found in the whole blood circulating throughout the torso inside four hours, so settled in large concentrations in the ovaries, bone marrow and lymph nodes.

Malone said there needed to exist monitoring of vaccine recipients for leukemia and lymphomas every bit there were concentrations of lipid nanoparticles in the bone marrow and lymph nodes. But those signals often don't prove upward for six months to nine years down the route, he said.

Usually, signals like this are picked up in animal studies and long-term clinical trials, but this didn't happen with mRNA vaccines, Malone said. There are two adverse event signals that are becoming apparent to the U.S. Nutrient and Drug Administration (FDA). One of them is thrombocytopenia — not having enough platelets, which are manufactured in the os marrow. The other is reactivation of latent viruses.

Malone found the ovarian bespeak perplexing because there is no accumulation in the testes.

Malone said the original information packages contained this biodistribution data. "This data has been out at that place a long time" within the protected, non-disclosed, purview of the regulators across the world, he said.

According to Malone, the FDA knew the COVID spike protein was biologically agile and could travel from the injection site and cause adverse events, and that the spike protein, if biologically active, is very dangerous.

In fact, Malone was one of many scientists to warn the FDA about the dangers of the gratis spike protein.

Malone suggested autoimmune issues may exist related to free-circulating spike protein which developers assured would non happen. To option upwards autoimmune issues, a two- to iii- yr follow-up menstruum in phase 3 patients would be required to monitor for potential autoimmune consequences from vaccines — just that monitoring didn't happen with the Pfizer and Moderna vaccines.

Pfizer and Moderna also didn't bear proper brute studies, Weinstein said. What the beast models give us is a signal that alerts us to what we demand to follow upward on in humans. Weinstein said:

"We've got very alarming brusk-term stuff. We've got short-term stuff that is alarming on the footing of where we find these lipids, where nosotros find the fasten proteins — those things are reasons for concern because it wasn't supposed to be this style. We've also got an alarming bespeak in terms of the hazards and deaths or the harms and the deaths that are reported in the system and there are reasons to think they are dramatic under-reports."

Vaden Bossche got it right

One of the potential harms from the vaccines, Weinstein said, was made famous by Vanden Bossche, a vaccinologist who worked with GSK Biologicals, Novartis Vaccines, Solvay Biologicals, Pecker & Melinda Gates Foundation's Global Health Discovery squad in Seattle, and Global Alliance for Vaccines and Immunization in Geneva.

Before this yr, Vanden Bossche put out a call to the Earth Wellness Organization, supported past a 12-page document , that described the "uncontrollable monster" that a global mass vaccination campaign could potentially unleash.

Vanden Bossche said a combination of lockdowns, and extreme selection pressure on the virus induced by the intense global mass vaccination program, might diminish the number of cases, hospitalizations and deaths in the curt-term, but ultimately, will induce the cosmos of more mutants of concern. This is what Vanden Bossche calls "immune escape" (i.e. incomplete sterilization of the virus by the man immune arrangement, even following vaccine administration).

Immune escape volition in plow trigger vaccine companies to further refine vaccines that volition add together, not reduce, the selection pressure, producing ever more transmissible and potentially deadly variants.

The selection force per unit area will cause greater convergence in mutations that affect the critical spike protein of the virus that is responsible for breaking through the mucosal surfaces of our airways, the route used by the virus to enter the human being torso.

The virus will effectively outsmart the highly specific antigen-based vaccines being used and tweaked, depending on the circulating variants. All of this could lead to a hockey stick-like increase in serious and potentially lethal cases — in effect, an out-of-command pandemic.

Malone said:

"Vanden Bossche'south business organization is not theoretical. It is real and we have the information. Nosotros're stuck with this virus or its downstream variants pretty much for the residue of our lives and it'southward going to go more like the flu. We will have continuing evolution and apportionment of variants, and that is an escape."